Sino Medical Sciences Technology Inc. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 165.93 million compared to CNY 121.13 million a year ago. Revenue was CNY 165.93 million compared to CNY 121.13 million a year ago.

Net loss was CNY 108.93 million compared to CNY 111.13 million a year ago. Basic loss per share from continuing operations was CNY 0.27 compared to CNY 0.27 a year ago. Diluted loss per share from continuing operations was CNY 0.27 compared to CNY 0.27 a year ago.